NASDAQ:MBIO - Mustang Bio News Headlines

$4.65
+0.60 (+14.81 %)
(As of 08/22/2019 01:33 AM ET)
Today's Range
$4.06
Now: $4.65
$4.83
50-Day Range
$2.77
MA: $3.35
$4.55
52-Week Range
$2.18
Now: $4.65
$10.20
Volume755,399 shs
Average Volume538,646 shs
Market Capitalization$188.09 million
P/E RatioN/A
Dividend YieldN/A
Beta2.38

Headlines

Mustang Bio (NASDAQ MBIO) News Headlines

Source:
DateHeadline
Mustang Bio Inc (NASDAQ:MBIO) Expected to Announce Earnings of -$0.27 Per ShareMustang Bio Inc (NASDAQ:MBIO) Expected to Announce Earnings of -$0.27 Per Share
www.americanbankingnews.com - August 18 at 6:17 AM
Short Interest in Mustang Bio Inc (NASDAQ:MBIO) Declines By 8.9%Short Interest in Mustang Bio Inc (NASDAQ:MBIO) Declines By 8.9%
www.americanbankingnews.com - August 16 at 11:57 PM
Q3 2019 EPS Estimates for Mustang Bio Inc (NASDAQ:MBIO) Decreased by AnalystQ3 2019 EPS Estimates for Mustang Bio Inc (NASDAQ:MBIO) Decreased by Analyst
www.americanbankingnews.com - August 15 at 5:46 AM
31 Stocks Moving In Tuesdays Pre-Market Session31 Stocks Moving In Tuesday's Pre-Market Session
www.msn.com - August 13 at 9:43 PM
Mustang Bio announces $9M grant to fund CAR T studyMustang Bio announces $9M grant to fund CAR T study
seekingalpha.com - August 13 at 12:17 PM
Mustang Bio (NASDAQ:MBIO) Now Covered by HC WainwrightMustang Bio (NASDAQ:MBIO) Now Covered by HC Wainwright
www.americanbankingnews.com - August 13 at 8:03 AM
Mustang Bio to Present at 11th Annual Bioprocessing SummitMustang Bio to Present at 11th Annual Bioprocessing Summit
finance.yahoo.com - August 12 at 11:38 AM
Mustang Bio Reports Second Quarter 2019 Financial Results and Recent Corporate HighlightsMustang Bio Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
finance.yahoo.com - August 9 at 4:30 PM
FDA clears Mustang Bio’s IND for MB-102FDA clears Mustang Bio’s IND for MB-102
seekingalpha.com - August 5 at 11:00 AM
The Mustang Bio (NASDAQ:MBIO) Share Price Is Down 52% So Some Shareholders Are Wishing They SoldThe Mustang Bio (NASDAQ:MBIO) Share Price Is Down 52% So Some Shareholders Are Wishing They Sold
finance.yahoo.com - July 10 at 4:05 PM
Mustang Bio +8.6% as Cantor sees 108% upsideMustang Bio +8.6% as Cantor sees 108% upside
seekingalpha.com - June 20 at 9:26 PM
Mustang Bio beats by $0.03Mustang Bio beats by $0.03
seekingalpha.com - May 10 at 11:26 AM
Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate HighlightsMustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
finance.yahoo.com - May 10 at 11:26 AM
Mustang Bio off 12% after pricing stock offeringMustang Bio off 12% after pricing stock offering
seekingalpha.com - April 30 at 11:07 AM
The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio OfferingThe Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering
finance.yahoo.com - April 30 at 11:07 AM
Mustang Bio Announces Pricing of Public Offering of Common StockMustang Bio Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - April 30 at 11:07 AM
Mustang Bio readies stock offering; shares down 11% after hoursMustang Bio readies stock offering; shares down 11% after hours
seekingalpha.com - April 29 at 4:15 PM
Mustang Bio Announces Proposed Public Offering of Common StockMustang Bio Announces Proposed Public Offering of Common Stock
finance.yahoo.com - April 29 at 4:15 PM
Is Mustang Bio the Next Great Biotech Stock?Is Mustang Bio the Next Great Biotech Stock?
investorplace.com - April 23 at 5:18 AM
Thinking about buying stock in Aurora Cannabis Inc., Keyw Holding Corp., Mustang Bio Inc., Tesla Inc., or Exxon Mobil Corp.?Thinking about buying stock in Aurora Cannabis Inc., Keyw Holding Corp., Mustang Bio Inc., Tesla Inc., or Exxon Mobil Corp.?
www.prnewswire.com - April 22 at 10:49 AM
Mustang Bio shares triple in price on new bubble boy therapy dataMustang Bio shares triple in price on new 'bubble boy' therapy data
seekingalpha.com - April 19 at 4:20 PM
Mustang Bio top gainer in market on positive gene therapy data in rare immune disorderMustang Bio top gainer in market on positive gene therapy data in rare immune disorder
seekingalpha.com - April 19 at 11:21 AM
Benzinga Pro Movers: Mustang Bio Shares Spike After Clinical Trial Data Is ReleasedBenzinga Pro Movers: Mustang Bio Shares Spike After Clinical Trial Data Is Released
www.benzinga.com - April 19 at 11:21 AM
Mustang Bios stock soars to near 4-fold gain after deal to commercialize bubble boy disease treatmentMustang Bio's stock soars to near 4-fold gain after deal to commercialize 'bubble boy' disease treatment
www.marketwatch.com - April 18 at 11:51 AM
Meet Mustang Bio’s Breakthrough ‘Bubble Boy’ TreatmentMeet Mustang Bio’s Breakthrough ‘Bubble Boy’ Treatment
247wallst.com - April 18 at 11:51 AM
Biotech News Recap: Mustang Bio Soars On XSCID DataBiotech News Recap: Mustang Bio Soars On XSCID Data
seekingalpha.com - April 18 at 11:51 AM
Mustang Bio teams up with leading childrens hospital to develop oncolytic virus for brain cancerMustang Bio teams up with leading children's hospital to develop oncolytic virus for brain cancer
seekingalpha.com - February 20 at 11:58 AM
Mustang Bio: Stocks Decline Opens Up Significant Potential For Late 2019Mustang Bio: Stock's Decline Opens Up Significant Potential For Late 2019
seekingalpha.com - January 30 at 11:04 AM
Mustang Bio Inc.Mustang Bio Inc.
www.barrons.com - December 28 at 10:48 AM
Mustang Bios MB-102 an Orphan Drug in U.S. for rare type of blood cancer; shares up 1%Mustang Bio's MB-102 an Orphan Drug in U.S. for rare type of blood cancer; shares up 1%
seekingalpha.com - December 20 at 3:49 PM
Need To Know: Mustang Bio, Inc. (NASDAQ:MBIO) Insiders Have Been Buying SharesNeed To Know: Mustang Bio, Inc. (NASDAQ:MBIO) Insiders Have Been Buying Shares
finance.yahoo.com - December 20 at 3:49 PM
MBIO: Mustang: A Steed on the Fast TrackMBIO: Mustang: A Steed on the Fast Track
finance.yahoo.com - December 17 at 10:53 AM
DPS Group and Hodess Cleanroom Construction Complete Proprietary Cell Therapy Manufacturing Facility for Mustang BioDPS Group and Hodess Cleanroom Construction Complete Proprietary Cell Therapy Manufacturing Facility for Mustang Bio
www.marketwatch.com - November 28 at 10:59 AM
Mustang Bio Announces Presentation of MB-102 (CD123 CAR) Safety and Efficacy Data at AACR Special Conference on Tumor Immunology and ImmunotherapyMustang Bio Announces Presentation of MB-102 (CD123 CAR) Safety and Efficacy Data at AACR Special Conference on Tumor Immunology and Immunotherapy
finance.yahoo.com - November 28 at 10:59 AM
Mustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate HighlightsMustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
finance.yahoo.com - November 14 at 10:05 AM
Early-stage study of Mustang Bios CAR T therapy in HER2+ breast cancer with brain metastases launchedEarly-stage study of Mustang Bio's CAR T therapy in HER2+ breast cancer with brain metastases launched
seekingalpha.com - October 30 at 3:39 PM
City of Hope Opens First-of-Its-Kind CAR T Clinical Trial for Patients With HER2-positive Breast Cancer That Has Spread to the BrainCity of Hope Opens First-of-Its-Kind CAR T Clinical Trial for Patients With HER2-positive Breast Cancer That Has Spread to the Brain
www.marketwatch.com - October 30 at 10:28 AM
What Investors Should Know About Mustang Bio Inc’s (NASDAQ:MBIO) Financial StrengthWhat Investors Should Know About Mustang Bio Inc’s (NASDAQ:MBIO) Financial Strength
finance.yahoo.com - October 16 at 3:33 PM
Mustang Bio appoints Martina A. Sersch as Chief Medical OfficerMustang Bio appoints Martina A. Sersch as Chief Medical Officer
seekingalpha.com - October 15 at 9:58 AM
Mustang Bio Sees Hammer Chart Pattern: Time to Buy?Mustang Bio Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - September 7 at 10:21 AM
Mustang Bio: Prudent Expansion Into Gene TherapyMustang Bio: Prudent Expansion Into Gene Therapy
seekingalpha.com - August 24 at 3:33 PM
Mustang Bio teams up with St. Jude Childrens Research Hospital to develop gene therapy for bubble boy diseaseMustang Bio teams up with St. Jude Children's Research Hospital to develop gene therapy for bubble boy disease
seekingalpha.com - August 13 at 10:06 AM
St. Jude and Mustang Bio enter into exclusive worldwide license agreementSt. Jude and Mustang Bio enter into exclusive worldwide license agreement
finance.yahoo.com - August 13 at 10:06 AM
Mustang Bio and St. Jude Children’s Research Hospital Enter into Exclusive Worldwide License Agreement for a Ground-Breaking, Clinical-Stage Lentiviral Gene Therapy with Curative Potential for X-linked Severe Combined ImmunodeficiencyMustang Bio and St. Jude Children’s Research Hospital Enter into Exclusive Worldwide License Agreement for a Ground-Breaking, Clinical-Stage Lentiviral Gene Therapy with Curative Potential for X-linked Severe Combined Immunodeficiency
finance.yahoo.com - August 13 at 10:06 AM
Rounds Report: Mustang Bio Pushed Ahead In The CAR-T RaceRounds Report: Mustang Bio Pushed Ahead In The CAR-T Race
seekingalpha.com - August 2 at 11:10 AM
Mustang Bio: What The Latest Development For MB-102 EntailsMustang Bio: What The Latest Development For MB-102 Entails
seekingalpha.com - July 29 at 9:16 AM
Mustang Bio (MBIO) Reports Complete Pre-IND Meeting with FDA for MB-102 (CD123 CAR T)Mustang Bio (MBIO) Reports Complete Pre-IND Meeting with FDA for MB-102 (CD123 CAR T)
www.streetinsider.com - July 19 at 9:53 AM
Mustang Bio Completes Pre-IND Meeting with FDA for MB-102 (CD123 CAR T)Mustang Bio Completes Pre-IND Meeting with FDA for MB-102 (CD123 CAR T)
finance.yahoo.com - July 19 at 9:53 AM
Mustang Bio opens CAR T cell therapy manufacturing facility in WorcesterMustang Bio opens CAR T cell therapy manufacturing facility in Worcester
seekingalpha.com - June 22 at 12:28 PM
Mustang Bios optimized CAR-T therapy shows encouraging action in preclinical testing; shares ahead 3%Mustang Bio's optimized CAR-T therapy shows encouraging action in preclinical testing; shares ahead 3%
seekingalpha.com - May 30 at 3:30 PM
This page was last updated on 8/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel